Viemed reports record Q4 revenue $50.7M (+35% YoY); net income up 43%

VIEMED HEALTHCARE, INC.

Q4 2023 revenue $50.7M, up 35% from $37.5M in Q4 2022; full-year revenue $183.0M, up 32%.
Q4 net income $3.5M (+43% YoY); full-year net income $10.2M (+65% YoY), seventh consecutive profitable year.
Adjusted EBITDA for Q4 $12.8M; full-year record $43.1M.
Company highlights record quarterly and annual net revenues driven by respiratory care services growth.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

VIEMED HEALTHCARE, INC. reported the three months and year ended December 31, 2023 results: revenue $50.7 million, net income $3.5 million.

Period: the three months and year ended December 31, 2023
Revenue: $50.7 million
Net income: $3.5 million
Result: reported results

Exact text from the filing

and year ended December 31, 2023. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended December 31, 2023 reached a new Company record of $50.7 million representing an increase of $13.2 million, or 35%, over net revenues reported for the comparable quarter ended December 31, 2022. Total net revenues for the year ended December

View on SEC.gov

Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-24-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.